Eurofins Genomics

Executive Summary

Eurofins Genomics is a leading international provider of DNA sequencing services, oligonucleotide synthesis, and bioinformatics solutions, operating since 1999 and headquartered in Louisville, USA. With a strong focus on customer orientation, fast turnaround times, and high-quality products, the company serves a broad range of clients in research, diagnostics, and therapeutics. Its advanced oligonucleotide design tools and comprehensive service portfolio position it well within the rapidly growing genomics and diagnostics markets. As a private entity within the larger Eurofins Scientific network, the company benefits from significant resources and cross-selling opportunities. Eurofins Genomics is poised to capitalize on the increasing demand for genomic analysis in precision medicine, agricultural biotechnology, and infectious disease surveillance.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation oligonucleotide synthesis platform70% success
• Q2 2027Expansion of bioinformatics services for clinical genomics60% success
• Q3 2026Partnership with major pharmaceutical company for sequencing services50% success